EU Pharma Business Development Manager

Contenu de l'offre EU Pharma Business Development Manager chez HalioDx

Start of mission: 15.04.2021 Job city: Marseille (Luminy) Type of contract: Full time

Job description

The EU Pharma Business Development Manager will support the growth of the Company's Pharma Business and will be a key member of the EU Pharma Business Development team. Primarily focusing on the development and execution of the EU account plan for the assigned territory, the objective of the EU Pharma Business Development Manager will be to achieve or exceed corresponding annual financial targets.

You will report to the EU Pharma BD Associate Director, located in Marseille, France.

Role & Responsibilities :

Promote HalioDx Pharma services to Pharma and Biotech companies in Europe. Primarily concentrates on the acquisition of new customers, preparing scientific presentations tailored to target pharma drugs and marker programs, providing scientific support and coordinating technical content input for inclusion in business proposals. Responsible for the growth of the company's Pharma Business Unit in Europe: develops and executes the account plan for the assigned territory, and achieves or exceeds corresponding annual financial targets (bookings, revenues...). Contribute to the Pharma BD team revenues target. Be a proactive and inspirational advocate for HalioDx

Profile

Qualifications/Requirements :

Communication and negotiation skills, able to clearly explain complex offerings to diverse audiences in a wide range of contexts (conferences, client presentations, multi-disciplinary teams...) Approximately 2-5 years' experience working in Pharma Business Development, or in Service Selling Companies (CRO for example), preferably in oncology Advanced degree in science or medicine with a Postgraduate (PhD) degree in a relevant biology field (Immunology, Microbiology...) preferred. Ability to work effectively in a dynamic, start-up environment Multi-cultural work experience, fluent in English Ability to travel up to 30% in Europe and internationally occasionally.